Cargando…
Baseline Microglial Activation Correlates With Brain Amyloidosis and Longitudinal Cognitive Decline in Alzheimer Disease
BACKGROUND AND OBJECTIVES: This study aims to quantify microglial activation in individuals with Alzheimer disease (AD) using the 18-kDa translocator protein (TSPO) PET imaging in the hippocampus and precuneus, the 2 AD-vulnerable regions, and to evaluate the association of baseline neuroinflammatio...
Autores principales: | , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8906187/ https://www.ncbi.nlm.nih.gov/pubmed/35260470 http://dx.doi.org/10.1212/NXI.0000000000001152 |
_version_ | 1784665355593973760 |
---|---|
author | Wang, Qing Chen, Gengsheng Schindler, Suzanne E. Christensen, Jon McKay, Nicole S. Liu, Jingxia Wang, Sicheng Sun, Zhexian Hassenstab, Jason Su, Yi Flores, Shaney Hornbeck, Russ Cash, Lisa Cruchaga, Carlos Fagan, Anne M. Tu, Zhude Morris, John C. Mintun, Mark A. Wang, Yong Benzinger, Tammie L.S. |
author_facet | Wang, Qing Chen, Gengsheng Schindler, Suzanne E. Christensen, Jon McKay, Nicole S. Liu, Jingxia Wang, Sicheng Sun, Zhexian Hassenstab, Jason Su, Yi Flores, Shaney Hornbeck, Russ Cash, Lisa Cruchaga, Carlos Fagan, Anne M. Tu, Zhude Morris, John C. Mintun, Mark A. Wang, Yong Benzinger, Tammie L.S. |
author_sort | Wang, Qing |
collection | PubMed |
description | BACKGROUND AND OBJECTIVES: This study aims to quantify microglial activation in individuals with Alzheimer disease (AD) using the 18-kDa translocator protein (TSPO) PET imaging in the hippocampus and precuneus, the 2 AD-vulnerable regions, and to evaluate the association of baseline neuroinflammation with amyloidosis, tau, and longitudinal cognitive decline. METHODS: Twenty-four participants from the Knight Alzheimer Disease Research Center (Knight ADRC) were enrolled and classified into stable cognitively normal, progressor, and symptomatic AD groups based on clinical dementia rating (CDR) at 2 or more clinical assessments. The baseline TSPO radiotracer [11C]PK11195 was used to image microglial activation. Baseline CSF concentrations of Aβ42, Aβ42/Aβ40 ratio, tau phosphorylated at position 181 (p-tau181), and total tau (t-tau) were measured. Clinical and cognitive decline were examined with longitudinal CDR and cognitive composite scores (Global and Knight ADRC-Preclinical Alzheimer Cognitive Composite [Knight ADRC-PACC] Score). RESULTS: Participants in the progressor and symptomatic AD groups had significantly elevated [11C]PK11195 standard uptake value ratios (SUVRs) in the hippocampus but not in the precuneus region. In the subcohort with CSF biomarkers (16 of the 24), significant negative correlations between CSF Aβ42 or Aβ42/Aβ40 and [11C]PK11195 SUVR were observed in the hippocampus and precuneus. No correlations were observed between [11C]PK11195 SUVR and CSF p-tau181 or t-tau at baseline in those regions. Higher baseline [11C]PK11195 SUVR averaged in the whole cortical regions predicted longitudinal decline on cognitive tests. DISCUSSION: Microglial activation is increased in individuals with brain amyloidosis and predicts worsening cognition in AD. CLASSIFICATION OF EVIDENCE: This study provides Class II evidence that in patients with AD, higher baseline [11C]PK11195 SUVR averaged in the whole cortical regions was associated with longitudinal decline on cognitive tests. |
format | Online Article Text |
id | pubmed-8906187 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Lippincott Williams & Wilkins |
record_format | MEDLINE/PubMed |
spelling | pubmed-89061872022-03-09 Baseline Microglial Activation Correlates With Brain Amyloidosis and Longitudinal Cognitive Decline in Alzheimer Disease Wang, Qing Chen, Gengsheng Schindler, Suzanne E. Christensen, Jon McKay, Nicole S. Liu, Jingxia Wang, Sicheng Sun, Zhexian Hassenstab, Jason Su, Yi Flores, Shaney Hornbeck, Russ Cash, Lisa Cruchaga, Carlos Fagan, Anne M. Tu, Zhude Morris, John C. Mintun, Mark A. Wang, Yong Benzinger, Tammie L.S. Neurol Neuroimmunol Neuroinflamm Article BACKGROUND AND OBJECTIVES: This study aims to quantify microglial activation in individuals with Alzheimer disease (AD) using the 18-kDa translocator protein (TSPO) PET imaging in the hippocampus and precuneus, the 2 AD-vulnerable regions, and to evaluate the association of baseline neuroinflammation with amyloidosis, tau, and longitudinal cognitive decline. METHODS: Twenty-four participants from the Knight Alzheimer Disease Research Center (Knight ADRC) were enrolled and classified into stable cognitively normal, progressor, and symptomatic AD groups based on clinical dementia rating (CDR) at 2 or more clinical assessments. The baseline TSPO radiotracer [11C]PK11195 was used to image microglial activation. Baseline CSF concentrations of Aβ42, Aβ42/Aβ40 ratio, tau phosphorylated at position 181 (p-tau181), and total tau (t-tau) were measured. Clinical and cognitive decline were examined with longitudinal CDR and cognitive composite scores (Global and Knight ADRC-Preclinical Alzheimer Cognitive Composite [Knight ADRC-PACC] Score). RESULTS: Participants in the progressor and symptomatic AD groups had significantly elevated [11C]PK11195 standard uptake value ratios (SUVRs) in the hippocampus but not in the precuneus region. In the subcohort with CSF biomarkers (16 of the 24), significant negative correlations between CSF Aβ42 or Aβ42/Aβ40 and [11C]PK11195 SUVR were observed in the hippocampus and precuneus. No correlations were observed between [11C]PK11195 SUVR and CSF p-tau181 or t-tau at baseline in those regions. Higher baseline [11C]PK11195 SUVR averaged in the whole cortical regions predicted longitudinal decline on cognitive tests. DISCUSSION: Microglial activation is increased in individuals with brain amyloidosis and predicts worsening cognition in AD. CLASSIFICATION OF EVIDENCE: This study provides Class II evidence that in patients with AD, higher baseline [11C]PK11195 SUVR averaged in the whole cortical regions was associated with longitudinal decline on cognitive tests. Lippincott Williams & Wilkins 2022-03-08 /pmc/articles/PMC8906187/ /pubmed/35260470 http://dx.doi.org/10.1212/NXI.0000000000001152 Text en Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License 4.0 (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) , which permits downloading and sharing the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal. |
spellingShingle | Article Wang, Qing Chen, Gengsheng Schindler, Suzanne E. Christensen, Jon McKay, Nicole S. Liu, Jingxia Wang, Sicheng Sun, Zhexian Hassenstab, Jason Su, Yi Flores, Shaney Hornbeck, Russ Cash, Lisa Cruchaga, Carlos Fagan, Anne M. Tu, Zhude Morris, John C. Mintun, Mark A. Wang, Yong Benzinger, Tammie L.S. Baseline Microglial Activation Correlates With Brain Amyloidosis and Longitudinal Cognitive Decline in Alzheimer Disease |
title | Baseline Microglial Activation Correlates With Brain Amyloidosis and Longitudinal Cognitive Decline in Alzheimer Disease |
title_full | Baseline Microglial Activation Correlates With Brain Amyloidosis and Longitudinal Cognitive Decline in Alzheimer Disease |
title_fullStr | Baseline Microglial Activation Correlates With Brain Amyloidosis and Longitudinal Cognitive Decline in Alzheimer Disease |
title_full_unstemmed | Baseline Microglial Activation Correlates With Brain Amyloidosis and Longitudinal Cognitive Decline in Alzheimer Disease |
title_short | Baseline Microglial Activation Correlates With Brain Amyloidosis and Longitudinal Cognitive Decline in Alzheimer Disease |
title_sort | baseline microglial activation correlates with brain amyloidosis and longitudinal cognitive decline in alzheimer disease |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8906187/ https://www.ncbi.nlm.nih.gov/pubmed/35260470 http://dx.doi.org/10.1212/NXI.0000000000001152 |
work_keys_str_mv | AT wangqing baselinemicroglialactivationcorrelateswithbrainamyloidosisandlongitudinalcognitivedeclineinalzheimerdisease AT chengengsheng baselinemicroglialactivationcorrelateswithbrainamyloidosisandlongitudinalcognitivedeclineinalzheimerdisease AT schindlersuzannee baselinemicroglialactivationcorrelateswithbrainamyloidosisandlongitudinalcognitivedeclineinalzheimerdisease AT christensenjon baselinemicroglialactivationcorrelateswithbrainamyloidosisandlongitudinalcognitivedeclineinalzheimerdisease AT mckaynicoles baselinemicroglialactivationcorrelateswithbrainamyloidosisandlongitudinalcognitivedeclineinalzheimerdisease AT liujingxia baselinemicroglialactivationcorrelateswithbrainamyloidosisandlongitudinalcognitivedeclineinalzheimerdisease AT wangsicheng baselinemicroglialactivationcorrelateswithbrainamyloidosisandlongitudinalcognitivedeclineinalzheimerdisease AT sunzhexian baselinemicroglialactivationcorrelateswithbrainamyloidosisandlongitudinalcognitivedeclineinalzheimerdisease AT hassenstabjason baselinemicroglialactivationcorrelateswithbrainamyloidosisandlongitudinalcognitivedeclineinalzheimerdisease AT suyi baselinemicroglialactivationcorrelateswithbrainamyloidosisandlongitudinalcognitivedeclineinalzheimerdisease AT floresshaney baselinemicroglialactivationcorrelateswithbrainamyloidosisandlongitudinalcognitivedeclineinalzheimerdisease AT hornbeckruss baselinemicroglialactivationcorrelateswithbrainamyloidosisandlongitudinalcognitivedeclineinalzheimerdisease AT cashlisa baselinemicroglialactivationcorrelateswithbrainamyloidosisandlongitudinalcognitivedeclineinalzheimerdisease AT cruchagacarlos baselinemicroglialactivationcorrelateswithbrainamyloidosisandlongitudinalcognitivedeclineinalzheimerdisease AT faganannem baselinemicroglialactivationcorrelateswithbrainamyloidosisandlongitudinalcognitivedeclineinalzheimerdisease AT tuzhude baselinemicroglialactivationcorrelateswithbrainamyloidosisandlongitudinalcognitivedeclineinalzheimerdisease AT morrisjohnc baselinemicroglialactivationcorrelateswithbrainamyloidosisandlongitudinalcognitivedeclineinalzheimerdisease AT mintunmarka baselinemicroglialactivationcorrelateswithbrainamyloidosisandlongitudinalcognitivedeclineinalzheimerdisease AT wangyong baselinemicroglialactivationcorrelateswithbrainamyloidosisandlongitudinalcognitivedeclineinalzheimerdisease AT benzingertammiels baselinemicroglialactivationcorrelateswithbrainamyloidosisandlongitudinalcognitivedeclineinalzheimerdisease |